Results 1 to 10 of about 5,086,971 (309)

Changes in molecular markers of Plasmodium falciparum drug resistance between 2017 and 2024 in Southern Benin. [PDF]

Int J Parasitol Drugs Drug Resist
Bohissou FET, Nahum D, Inoue J, Sondo P, Hounsou L, Sondjo G, Djègbè NDC, Woli R, Dossou S, Kpohonnou C, Tinto H, Held J.   +11 more
europepmc   +1 more source

Roles of lactate and lactylation in tumor immune suppression and drug resistance. [PDF]

Front Immunol
Li J, Yang W, Xin T, Zhou Z, Liu X, Tang P, An J, Ma B, Peng F.   +8 more
europepmc   +1 more source

REGγ Suppresses Ferroptosis and Induces Drug Resistance by Degrading WDR6 in Chondrosarcoma. [PDF]

Adv Sci (Weinh)
Liu F, Shen S, Li D, Shi P, Xu J, Lv T, Du Y, Zhang J, Yang B, Chen H, Peng Z, Ren W, Zhang L, Cheng S, Yin T, Sheng W, Li L, Wu J, Yang Q, Xu S, Zheng W.   +20 more
europepmc   +1 more source

USP5 in cancer: a therapeutic window into metabolism and drug resistance. [PDF]

J Transl Med
Li H, Wang H, Hu T.
europepmc   +1 more source

Nanocarrier strategies to overcome P-glycoprotein-mediated drug resistance in cancer therapy. [PDF]

Beilstein J Nanotechnol
Quevedo-Enríquez A, Zhang KY, Enriquez DY, Inapanta BR, Peroni RN, Quijia CR.   +5 more
europepmc   +1 more source

Conformational asymmetry of human immunodeficiency virus-1 protease flaps increases along the darunavir drug resistance pathway. [PDF]

Protein Sci
Guerrero M, Zadorozhnyi R, Lin G, Quinn CM, Calero G, Kurt-Yilmaz N, Schiffer CA, Polenova T, Gronenborn AM, Ishima R.   +9 more
europepmc   +1 more source

Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024. [PDF]

Antimicrob Agents Chemother
Katairo T, Asua V, Semakuba FD, Nsengimaana B, Kiyaga S, Hathaway N, Murie K, Tukwasibwe S, Wiringilimaana I, Nakasaanyaa J, Mwubaha C, Achom KB, Esilu TE, Ayitewalah A, Mbabazi M, Kabbale KD, Mulondo J, Watyekele E, Aranda-Diaz A, Maiteki CS, Opigo J, Dorsey G, Nsobya SL, Kamya MR, Agaba BB, Ssewanyana I, Greenhouse B, Rosenthal PJ, Briggs J, Conrad MD.   +29 more
europepmc   +1 more source

A Darwinian model for the evolution of drug resistance to long-acting PrEP during an early HIV infection. [PDF]

PLoS One
Gurski K, Kang Y, Ma Y.
europepmc   +1 more source